Stay updated on ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page revision version was updated from v3.5.2 to v3.5.3 without changing the underlying study information presented.
    Difference
    0.1%
    Check dated 2026-04-24T16:56:09.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T13:45:08.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    37 days ago
    Change Detected
    Summary
    Added Hepatocellular carcinoma as a study condition and a Genetic and Rare Diseases Information Center resource link. The page revision updated from v3.4.3 to v3.5.0.
    Difference
    0.2%
    Check dated 2026-03-19T22:15:50.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T20:01:53.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Minor UI/layout adjustments and an updated timestamp; no substantive changes to core study content such as eligibility, primary outcomes, or treatment details.
    Difference
    0.1%
    Check dated 2026-03-05T14:40:03.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    A new Revision: v3.4.2 is now visible. The funding lapse notice and the older Revision: v3.4.1 have been removed.
    Difference
    0.5%
    Check dated 2026-02-11T09:52:36.000Z thumbnail image

Stay in the know with updates to ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial page.